Amenorrhea: Clinical Trials

7 trials for Amenorrhea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 2 withdrawn, 1 recruiting. 7 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 2, Unknown 2, Withdrawn 2, Recruiting 1
Phase 22Completed 1, Recruiting 1

Follow Amenorrhea: new trials by email Literature Review of Amenorrhea trials Research Report on Amenorrhea

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women
Autologous PRP intra ovarian infusion, Autologous PFP intra ovarian infusion - Infertility, Female, Anovulatory Infertility
Phase 2 / Phase 3RecruitingGenesis Athens Clinic1002019-05-212026-07-08
Reflexology's Effect on Polycystic Ovary Syndrome (PCOS)
Reflexology - Polycystic Ovary Syndrome
Phase 3UnknownUniversity of Nottingham1402012-12-012012-12-04
Reflexology's Effect on Polycystic Ovary Syndrome: A Pilot Study
Reflexology - Polycystic Ovary Syndrome
Phase 3UnknownUniversity of Nottingham1402012-12-012012-12-04
Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes
Transdermal 17Beta-estradiol, progesterone, Ethinyl Estradiol + Desogestrel, Sham Comparator - Exercise-related Amenorrhea
Phase 3CompletedMassachusetts General Hospital1212009-05-012021-06-11
Bone Mass Accrual in Adolescent Athletes
Estrogen - Amenorrhea, Bone Loss
Phase 3WithdrawnMassachusetts General Hospital2008-12-012021-10-26
Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density
Seasonale (levonorgestrel and ethinyl estradiol) - Osteopenia
Phase 3WithdrawnDuramed Research2005-07-012013-08-12
Effects of Anorexia Nervosa on Bone Mass in Adolescents
Physiologic Estrogen/progesterone, Placebo - Anorexia Nervosa
Phase 2 / Phase 3CompletedMassachusetts General Hospital1102003-07-012021-11-02

Narrower conditions

Bone Diseases, Metabolic (3)  ·  Endocrine System Diseases (2)  ·  Polycystic Ovary Syndrome (2)  ·  Anorexia Nervosa (1)  ·  Infertility, Female (1)  ·  Osteoporosis (1)

Broader conditions

Menstruation Disturbances (7)  ·  Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Bone Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Metabolic Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Urogenital Diseases (3)  ·  Adnexal Diseases (2)  ·  Cysts (2)  ·  Gonadal Disorders (2)

Interventions

Progesterone (3)  ·  Musculoskeletal Manipulations (2)  ·  Desogestrel (1)  ·  Estradiol (1)  ·  Estrogens (1)  ·  Ethinyl Estradiol (1)  ·  Levonorgestrel (1)  ·  Seasonale (1)

Sponsors

Massachusetts General Hospital (3)  ·  University of Nottingham (2)  ·  Duramed Research (1)  ·  Genesis Athens Clinic (1)

Countries

United States (3)  ·  United Kingdom (2)  ·  Greece (1)

Top investigators

Dawn-Marie Walker, PhD (2)  ·  Agni Pantou, MD (1)  ·  Madhu Misra, MD, MPH (1)  ·  Madhusmita Misra, MD (1)  ·  Madhusmita Misra, MD, MPH (1)

Results publications

PMID 21698665, PMID 21816790, PMID 22252944, PMID 22728230, PMID 24021517, PMID 28297591, PMID 30301734, PMID 30476179, PMID 30639922, PMID 31603998

NIH funding

R01DK062249 (1), R01HD060827 (1)